Skip to main content
Salarius Pharmaceuticals, Inc. logo

Salarius Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · SLRX ISIN · US79400X4043 LEI · 549300CLUMLZXIHU7X22 US Professional, scientific and technical activities
Filings indexed 700 across all filing types
Latest filing 2016-03-18 Share Issue/Capital Cha…
Country US United States of America
Listing US SLRX

About Salarius Pharmaceuticals, Inc.

https://salariuspharma.com/

Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing therapies for cancer patients with high unmet medical needs. The company's core technology focuses on correcting the dysregulated gene expression of cancer cells, a key driver of disease development. Its pipeline includes two classes of drugs: targeted protein inhibitors (TPIs) and targeted protein degraders (TPDs). The lead TPI candidate, seclidemstat (SP-2577), is in Phase 1/2 clinical trials, while the lead TPD candidate, SP-3164, is in IND-enabling studies. These therapeutic candidates are being developed to treat solid and hematologic cancers, including leukemias and lymphomas.

Recent filings

Filing Released Lang Actions
S-8
Share Issue/Capital Change Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC. It registers additional shares of common stock under employee benefit plans (Equity Incentive Plan and Employee Stock Purchase Plan). The document includes details about the registration fee, incorporation by reference of prior filings, signatures of officers and directors, and exhibits related to corporate governance documents and legal opinions. Form S-8 is specifically used for registering securities to be offered under employee benefit plans and is a type of capital raising filing related to share issuance. It is not a financial report, earnings release, or management discussion. Therefore, the document fits the category of Share Issue/Capital Change announcements.
2016-03-18 English
FORM 4
Director's Dealing
2016-03-17 English
FORM 4
Director's Dealing
2016-03-16 English
FORM 4
Director's Dealing
2016-03-15 English
FORM 4
Director's Dealing
2016-03-15 English
FORM 4
Director's Dealing
2016-03-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.